Temozolomide-induced Thrombocytopenia
Showing 1 - 25 of >10,000
Thrombocytopenia Trial in Rochester (Avatrombopag)
Recruiting
- Thrombocytopenia
-
Rochester, New YorkUniversity of Rochester Medical Center
Jun 9, 2022
Chemo-induced Thrombocytopenia Trial in Shanghai (QL0911)
Completed
- Chemotherapy-induced Thrombocytopenia
-
Shanghai, Shanghai, ChinaShanghai East Hospital
May 5, 2023
Acute Suspected Heparin-induced Thrombocytopenia.
Not yet recruiting
- Heparin-induced Thrombocytopenia
-
Paris, FranceHopital Bichat-Claude Bernard
Sep 28, 2023
Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)
Not yet recruiting
- Chemotherapy-Induced Thrombocytopenia
- Hetrombopag Olamine
- (no location specified)
Jul 5, 2023
Chemo-Induced Thrombocytopenia Trial (Hetrombopag)
Not yet recruiting
- Chemotherapy-Induced Thrombocytopenia
- (no location specified)
Jul 24, 2023
Chemo-Induced Thrombocytopenia Trial (Hetrombopag, Hetrombopag plus Placebo, Placebo)
Not yet recruiting
- Chemotherapy-Induced Thrombocytopenia
- Hetrombopag
- +2 more
- (no location specified)
May 17, 2023
Heparin-induced Thrombocytopenia, HIT, Platelet Activation Trial in Amiens (blood sample)
Recruiting
- Heparin-induced Thrombocytopenia
- +7 more
- blood sample
-
Amiens, FranceCHU Amiens
Sep 12, 2023
Chemo-induced Thrombocytopenia Trial (Hetrombopag)
Not yet recruiting
- Chemotherapy-induced Thrombocytopenia
- (no location specified)
Oct 20, 2023
Chemo-induced Thrombocytopenia, Herombopag Trial in Tianjin (Herombopag)
Recruiting
- Chemotherapy-induced Thrombocytopenia
- Herombopag
-
Tianjin, Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Jan 24, 2023
Chemo-induced Thrombocytopenia, Avatrombopag Trial in Tianjin (Avatrombopag)
Recruiting
- Chemotherapy-induced Thrombocytopenia
- Avatrombopag
-
Tianjin, Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Jan 24, 2023
Chemo-induced Thrombocytopenia, Eltrombopag Trial in Tianjin (Eltrombopag)
Recruiting
- Chemotherapy-induced Thrombocytopenia
- Eltrombopag
-
Tianjin, Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Jan 24, 2023
Thrombocytopenia, Immune, Heparin Induced Thrombocytopenia Trial (VLX-1005, Placebo)
Not yet recruiting
- Thrombocytopenia, Immune
- Heparin Induced Thrombocytopenia
- VLX-1005
- Placebo
- (no location specified)
Mar 24, 2023
Linezolid Induced Thrombocytopenia Trial in Cairo (N acetyl cysteine)
Not yet recruiting
- Linezolid Induced Thrombocytopenia
- N acetyl cysteine
-
Cairo, Egypt15 May hospital
Jul 6, 2023
Chemo-induced Thrombocytopenia Trial in Shanghai (QL0911, Placebo)
Recruiting
- Chemotherapy-induced Thrombocytopenia
- QL0911
- Placebo
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Sep 21, 2022
Linezolid-induced Thrombocytopenia in Critically Ill Patients,
Recruiting
- Thrombocytopenia; Drugs
- Linezolid 600 mg
-
Cairo, Egypt15 May hospital
Jul 13, 2023
Heparin-induced Thrombocytopenia in Post-operative Cardiac
Recruiting
- Heparin-induced Thrombocytopenia
- Post screening diagnostic test
-
Vandœuvre-lès-Nancy, Meurthe Et Moselle, France'CHRU Nancy
Mar 23, 2023
Gastrointestinal Cancer, Gastrointestinal Tumors, Chemo-Induced Thrombocytopenia Trial in Miami, Boston (Avatrombopag, Matching
Not yet recruiting
- Gastrointestinal Cancer
- +2 more
- Avatrombopag
- Matching Placebo
-
Miami, Florida
- +1 more
Mar 6, 2023
Non-Hodgkin Lymphoma Trial in Milano (Romiplostim)
Completed
- Non-Hodgkin Lymphoma
-
Milano, ItalyDip. Oncoematologia - Fondazione Centro San Raffaele del Monte T
Aug 10, 2022
Dialysis; Complications, Heparin-induced Thrombocytopenia, Chronic Renal Failure Trial in Quincy-sous-Sénart (Hydrolink NV
Not yet recruiting
- Dialysis; Complications
- +2 more
- Hydrolink NV membrane
-
Quincy-sous-Sénart, FranceHôpital Privé Claude Galien
Oct 17, 2022
Chemo-induced Thrombocytopenia (CIT) Trial in Chengdu (Recombinant Human Tumor Necrosis Factor Receptor II -Fc-TPO Mimetic
Recruiting
- Chemotherapy-induced Thrombocytopenia (CIT)
- Recombinant Human Tumor Necrosis Factor Receptor II -Fc-TPO Mimetic Peptide Fusion Protein
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Jun 23, 2022
Thrombocytopenia Trial in Hefei (Avatrombopag)
Completed
- Thrombocytopenia
-
Hefei, Anhui, ChinaAnhui Provincial Cancer Hospital
Apr 24, 2022
Chemotherapy Solid Tumors Who Receiving Thrombocytopenia
Completed
- Chemotherapy-induced Thrombocytopenia
- Recombinant Human Interleukin-11 for Injection
-
Shenyang, Liaoning, ChinaXing Xiaojing
Jan 15, 2023
Breast Cancer Trial in Zhengzhou (Hetrombopag, rh-TPO)
Not yet recruiting
- Breast Cancer
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
May 26, 2022
Genomics and COVID-19 Vaccine Adverse Events
Recruiting
- Vaccine Adverse Reaction
- COVID-19 vaccines
-
Vancouver, British Columbia, CanadaBritish Columbia Children's Hospital Research Institute
Jun 24, 2022